Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression.
about
Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapyInhibition of c-Myc overcomes cytotoxic drug resistance in acute myeloid leukemia cells by promoting differentiationLipoplexes and tumours. A review.TCRP1 transcriptionally regulated by c-Myc confers cancer chemoresistance in tongue and lung cancer.The Dual Roles of MYC in Genomic Instability and Cancer ChemoresistanceThe c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells.Targeting c-MYC in Platinum-Resistant Ovarian CancerUse of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistanceCisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cellsC-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevanceTargeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy.Pre-treatment with a non-therapeutic dose of cisplatin increases solid tumour response to liposomal-p53 gene therapy- An in vivo study.Amelioration of cisplatin-induced nephrotoxicity in peroxiredoxin I-deficient mice.Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia.Genetic instability and recurrent MYC amplification in ALK-translocated NSCLC; a central role of TP53 mutations.Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors.
P2860
Q28541831-CB3C6B6A-E6A2-4D19-BFB7-B7B7AE0DEA45Q28542016-D57CB390-6CB1-4611-8D28-14C1F592DE0AQ33723073-2A29AE5B-8131-4135-8642-FD3335F7CD6EQ33807765-589D2AF0-D4DA-430E-81F6-11E78E052FC3Q33836799-E9DAF74C-31B9-402F-8922-A9529E061714Q35879510-F7BBB2FD-DEB9-45DE-A889-35CFC06106E1Q36132771-8A572847-74B5-4575-8B0F-0C8FEF0629A7Q36254793-C8D6D5DD-6670-4129-A137-36E46A0B075DQ36431436-A0225A3C-972F-4972-A1BB-4ECC971F4A91Q36621638-3BE566C3-08F4-48A8-9112-502317AF0A7DQ36920745-1E0D087B-1273-4C9B-9DE6-B0814B7B633DQ39630019-B2E4940D-1F01-4A12-882F-FDBA1A46FB84Q42517747-48B77662-A08E-4E2A-BDDD-7E51075B55E1Q51028662-0F2F2250-2AD4-49DC-8F60-546F5F158C5DQ54976636-F05B16FC-99E1-4A4D-AD04-D590AACBFDC6Q55403266-3E149E69-6D8A-4B7F-BCCD-02CD3F721FEA
P2860
Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression.
@ast
Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression.
@en
type
label
Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression.
@ast
Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression.
@en
prefLabel
Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression.
@ast
Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression.
@en
P2093
P2860
P356
P1476
Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1996.105
P407
P577
1996-03-01T00:00:00Z